Antimicrobial Resistance in Intensive Care Units in Somalia: A Commentary on Measurement Gaps and Facility-Level

Abdukadir Mohamed Hassan1, Ahmed Omar Siyad1, Abdiwali Mohamed Hussein2

  • 1Department of Intensive Care Unit, Dr. Sumait Hospital, SIMAD University, Mogadishu, Somalia.

Insights

Antimicrobial resistance (AMR) poses a significant challenge in intensive care units (ICUs). Implementing a minimum facility-level ICU AMR starter package with six linked actions is a pragmatic approach to combat resistant pathogens in Somalia.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Public health

Background:

  • Antimicrobial resistance (AMR) is a growing concern in intensive care units (ICUs) due to factors like high antibiotic use and invasive procedures.
  • Somalia is enhancing critical care services but faces challenges in infection prevention and control (IPC), microbiology, and antimicrobial stewardship (AMS).

Purpose of the Study:

  • To discuss pragmatic priorities for ICU AMR response in Somalia.
  • To propose a minimum facility-level ICU AMR starter package for local adaptation.

Main Methods:

  • Integration of frontline ICU experience from Mogadishu.
  • Targeted review of Somali hospital studies on AMR.
  • Application of WHO and CDC operational guidance.

Main Results:

  • Studies from Mogadishu indicate a substantial burden of multidrug-resistant organisms in ICUs and hospital-acquired infections.
  • Existing IPC and AMS systems show significant constraints.

Conclusions:

  • A minimum ICU AMR starter package comprising six linked actions is proposed as a realistic starting point.
  • This package includes defined accountability, audited IPC, useful microbiology outputs (antibiograms), antibiotic review, planned durations, and protection of last-line agents.
  • Strengthening measurement, IPC, and stewardship in sentinel hospitals can generate data for future policy and research.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...